Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder (OCD) affects 2.5% to 4% of the population and ranks as the seventh most debilitating illness globally, driven by a cycle where compulsions provide only fleeting relief for intrusive, recurrent obsessions. This condition is rooted in dysfunction within the corticostriatothalamic loop, a neural circuit governing perception and action selection. Exposure-based cognitive behavioral therapy serves as the gold-standard treatment, requiring patients to tolerate peak anxiety without engaging in ritualistic behaviors to effectively disrupt the circuit. While selective serotonin reuptake inhibitors (SSRIs) are frequently used, their efficacy lacks a clear causal link to the serotonin system. Emerging interventions, including transcranial magnetic stimulation (TMS) and nutraceuticals like myoinositol, offer potential avenues for symptom management, though they are most effective when integrated with behavioral therapies rather than used in isolation.